Normal human epithelial cells regulate the size and morphology of tissue-engineered capillaries.
The survival of thick tissues/organs produced by tissue engineering requires rapid revascularization after grafting. Although capillary-like structures have been reconstituted in some engineered tissues, little is known about the interaction between normal epithelial cells and endothelial cells involved in the in vitro angiogenic process. In the present study, we used the self-assembly approach of tissue engineering to examine this relationship. An endothelialized tissue-engineered dermal substitute was produced by adding endothelial cells to the tissue-engineered dermal substitute produced by the self-assembly approach. The latter consists in culturing fibroblasts in the medium supplemented with serum and ascorbic acid. A network of tissue-engineered capillaries (TECs) formed within the human extracellular matrix produced by dermal fibroblasts. To determine whether epithelial cells modify TECs, the size and form of TECs were studied in the endothelialized tissue-engineered dermal substitute cultured in the presence or absence of epithelial cells. In the presence of normal keratinocytes from skin, cornea or uterine cervix, endothelial cells formed small TECs (cross-sectional area estimated at less than 50 microm(2)) reminiscent of capillaries found in the skin's microcirculation. In contrast, TECs grown in the absence of epithelial cells presented variable sizes (larger than 50 microm(2)), but the addition of keratinocyte-conditioned media or exogenous vascular endothelial growth factor induced their normalization toward a smaller size. Vascular endothelial growth factor neutralization inhibited the effect of keratinocyte-conditioned media. These results provide new direct evidence that normal human epithelial cells play a role in the regulation of the underlying TEC network, and advance our knowledge in tissue engineering for the production of TEC networks in vitro.
Rochon
Marie-Hélène
MH
Laboratoire d'Organogénèse Expérimentale, Centre de recherche FRSQ du CHA Universitaire de Québec, Département de Chirurgie, Faculté de Médecine, Université Laval, Quebec, Canada .
Fradette
Julie
J
Fortin
Véronique
V
Tomasetig
Florence
F
Roberge
Charles J
CJ
Baker
Kathleen
K
Berthod
François
F
Auger
François A
FA
Germain
Lucie
L
D016475:3T3 Cells; D000818:Animals; D057134:Antibodies, Neutralizing; D002196:Capillaries / Q000033:anatomy & histology* / Q000166:cytology / Q000187:drug effects; D017077:Culture Media, Conditioned / Q000494:pharmacology; D004847:Epithelial Cells / Q000166:cytology* / Q000187:drug effects; D006801:Humans; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology; D017768:Skin, Artificial; D023822:Tissue Engineering / Q000379:methods*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism / Q000494:pharmacology
D057134:Antibodies, Neutralizing; D017077:Culture Media, Conditioned; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A